TABLE 1

Clinical drug-drug interactions with ketoconazole


Druga

Reported -Fold AUC Change

Commercial Availabilityb

Significant in Vitro Metabolic Clearancec
Alfuzosin 3.20
Alprazolam 3.98 Embedded Image
Aprepitant 5.00
Artemether 2.31
Bosentan 2.22
Budesonide 3.96–6.81 Embedded Image Embedded Image
Buprenorphine 2.30 Embedded Image Embedded Image
Cyclosporine 4.39 Embedded Image
Docetaxel 2.22 Embedded Image Embedded Image
Eletriptan 5.90
Eplerenone 5.40
Irinotecan 2.09 Embedded Image
Levomethadyl 5.53
Loratadine 3.47 Embedded Image Embedded Image
Methylprednisolone 2.36 Embedded Image Embedded Image
Midazolam 15.9 Embedded Image
Nisoldipine 25.3
Omeprazole 2.05 Embedded Image
Saquinavir 2.90
Sirolimus 10.9 Embedded Image Embedded Image
Tacrolimus 2.39 Embedded Image Embedded Image
Tretinoin 1.72 Embedded Image
Tadalafil 4.07
Tirilazad 4.09
Tolterodine 2.58
Triazolam 22.4 Embedded Image
Vardenafil 10.0
Zolpidem
1.67
Embedded Image

  • a Data from University of Washington DDI database handout (2004, http://www.duginteractioninfo.org)

  • b Available from Sigma-Aldrich

  • c Compounds were not in our previous study and had <60% remaining at the end of 15 min, 0.5 mg/ml microsomal incubation